Get the app
US › Healthcare

Brainsway Ltd (BWAY)

US · Healthcare · Medical Devices

$13.53+0.52%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$17.4M
Revenue YoY
+37.8%
Net profit
$2.8M
Profit YoY
+36.0%
EPS
$0.14
EPS estimate
$0.10
Net margin
15.8%

EPS came in at 0.14 against a street estimate of 0.10 — a beat of 40.0%.

Key statistics

Market cap
$541.2M
P/E
58.5
Forward P/E
18.2
P/B
6.92
Book value
$2.04
EPS (TTM)
$0.23
52-week high
$17.40
52-week low
$7.13
50-day MA
$15.07
200-day MA
$13.43
Beta
0.08

Analyst view

Analysts rate Brainsway Ltd a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $19.27.

Shareholding

Insiders
2.54%
Institutions
32.51%

Largest institutional holders

FundStake
Valor Management LLC13.22%
Masters Capital Management LLC3.73%
Acadian Asset Management LLC2.04%
Essex Investment Management Company, LLC1.47%
Renaissance Technologies Corp1.29%
Cresset Asset Management, LLC0.78%
Y.D. More Investments Ltd0.68%
SEI Investments Co0.56%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Brainsway Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.